ArticleFrontiers in nutrition2025
Global, regional, and national burden of iodine deficiency for women of reproductive age, 1990-2021: a systematic analysis based on the Global Burden of Disease Study 2021.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Thyroid disease burden among individuals aged 0-19 years in low-SDI countries, 1990-2035: a systematic analysis of the Global Burden of Disease Study 2023.Translational pediatrics · 2026Article
- Iodine levels in household and market salt, and associated knowledge, attitudes, and practices in Ethiopia: a nationwide cross-sectional study.BMC public health · 2026Article
- Beyond iodine nutrition: socioeconomic patterns independently drive thyroid disease risk in pregnant women in Xinjiang.Frontiers in nutrition · 2026Article
- Iodoquinoline-Biofortified Lettuce as a Safe and Bioavailable Dietary Iodine Source: In Vivo Study in Rats.Nutrients · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to assess the global, regional, and national burden of iodine deficiency among women of reproductive age (WRA) from 1990 to 2021. Methods: Utilizing data from the Global Burden of Disease Study 2021, this study reports age-standardized rates per 100,000 population and average annual percentage changes (AAPCs) in incidence, prevalence, and years lived with disability (YLD) of iodine deficiency among WRA, facilitating a comparative analysis of the burden across regions and nations. Moreover, Joinpoint analysis was utilized to assess temporal trends, the slope index and concentration index of inequality were used to assess the health inequality across countries. The Bayesian age-period-cohort model was employed to forecast the burden up to 2044. Results: A notable upward trend in the age-standardized incidence rate (ASIR) of iodine deficiency among WRA was observed globally from 1990 to 2021, and this trend is projected to remain relatively stable between 2021 and 2030. The global ASIR increase from 171.3 per 100,000 population (95% CI 122.8, 228.2) in 1990 to 193.6 (95% CI 141.7, 253.2) in 2021 with an AAPC at 0.36 (95% CI 0.26, 0.47). Moreover, the global age-standardized prevalence rate (ASPR) and age-standardized YLD rate (ASYR) demonstrated decreased trend with the AAPC of -0.31 (-0.35, -0.27) and -1.05 (-1.19, -0.92), respectively. In 2021, countries with low sociodemographic index (SDI) exhibited the highest iodine deficiency burden. The highest burden of iodine deficiency was observed in Central Sub-Saharan Africa, while East Asia exhibited the highest increase in ASIR, ASPR and ASYR. Women of 20-24 years showed the highest increase in the age specific incidence rate globally. The significant absolute and relative health inequality was also observed and the gap has been narrowed. Conclusions: Over the past three decades, there has been an overall upward trend in the ASIR of iodine deficiency among WRA globally. Health inequalities related to iodine deficiency was still prominent across countries. Iodine deficiency among WRA remains a significant public health issue. It is crucial to prioritize the development of effective, targeted strategies and implement monitoring mechanisms to enhance the iodine levels among WRA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.